We and others showed that NKT cells can show cytotoxicity against α-GalCer-loaded CD1d-expressing target cells, such as B16 melanoma, EL4 lymphoma, WHEI3B leukemia and NIH3T3 fibroblasts [16, 23]. The gene discussed is CD1D; the disease is melanoma.